Pelabresib,Ruxolitinib
morphosys
['$mor', 'morphosys']
$mor morphosys presents multiple analyses of the manifest phase 2 trial investigating the potential of pelabresib in the treatment of myelofibrosis at eha 2022 
Be the First to Know Which #PennyStocks Are Being Promoted - Not the Last! Real-Time #StockAlert Tracking and Monitoring: https://t.co/WLRj8z0R5p